Clinical Trial Update: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase I–II clinical trial evaluating HM781-36B in combination with paclitaxel and trastuzumab for HER-2 positive advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HM781-36B (HM781-36B)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: HER-2 Positive Advanced Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED